-transparent.png){kind=logo}
Nicotinic acid reduces the cholera-toxin induced fluid secretion in experimental animals but its toxicity at high doses prevent its therapeutic use in patients suffering from cholera. This study aimed to determine whether nicotinamide, the non toxic amide derivative of nicotinic acid, is as effective as nicotinic acid in inhibiting cholera toxin induced intestinal secretion in vivo. Four intestinal loops, with their blood supply intact, were isolated in 30 rabbits and injected with either (i) 30 mM mannitol, (ii) 30 mM mannitol + 10 micrograms cholera toxin, (iii) 30 mM glucose, or (iv) 30 mM glucose + 10 micrograms cholera toxin. These rabbits were then randomly assigned to three groups receiving intraluminally either 100 mg/kg of nicotinic acid, 100 mg/kg of nicotinamide, or 10 ml/kg of Ringer solution. Measurement of intestinal fluid accumulation showed that nicotinic acid, but not nicotinamide, significantly reduced cholera toxin induced intestinal secretion.
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
February 1990,
The Journal of physiology,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
November 1989,
Gastroenterology,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
October 1976,
Biochimica et biophysica acta,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
July 1979,
Gastroenterology,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
September 1981,
The American journal of physiology,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
July 1986,
Digestive diseases and sciences,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
May 2000,
American journal of physiology. Gastrointestinal and liver physiology,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
February 1983,
Gut,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
December 1988,
Pediatric research,
A Briend, and
S K Nath, and
M Heyman, and
J F Desjeux
January 1991,
Journal de physiologie,
